Clinical Trials to Validate the Use of Additioned Endoscopy in Endoscopic Retrograde Cholangiopancreatography
Not Applicable
- Conditions
- ERCP
- Interventions
- Device: Additioned Endoscopy
- Registration Number
- NCT03350555
- Lead Sponsor
- Changhai Hospital
- Brief Summary
Validation of clinical use of additioned endoscopy in Endoscopic Retrograde Cholangiopancreatography(ERCP) treatment.
- Detailed Description
Investigators recently developed a device named additioned Endoscopy. The purpose of current clinical trial is to evaluate the use of additioned endoscopy in ERCP treatment, specifically in shortening the duration of ERCP operation and lowering incidence of complications.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- People who are indicated to ERCP treatment.
Exclusion Criteria
- People who are not suitable for ERCP treatment.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ERCP with additioned endoscopy Additioned Endoscopy This arm will include participants undergoing ERCP with assistance of additioned endoscopy.
- Primary Outcome Measures
Name Time Method Duration of ERCP treatment Duration of operation in each patient, ie. from beginning to the end of ERCP operation in each patient To test if additioned endoscopy will have impact on duration of ERCP treatment
- Secondary Outcome Measures
Name Time Method complications of ERCP treatment up to 1 month after ERCP completion To test if additioned endoscopy will have impact on incidence of ERCP complications, including perforation, bleeding, post-ERCP pancreatitis.
Trial Locations
- Locations (1)
Changhai Hospital, Second Military Medical University
🇨🇳Shanghai, Shanghai, China